Patent details

EP2694088 Title: MACROPHAGE ACTIVATING FACTOR FOR PHARMACEUTICAL COMPOSITIONS

Basic Information

Publication number:
EP2694088
PCT Application Number:
IL2012000159
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127680916
PCT Publication Number:
WO2012137199
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MACROPHAGE ACTIVATING FACTOR FOR PHARMACEUTICAL COMPOSITIONS
French Title of Invention:
FACTEUR D'ACTIVATION DES MACROPHAGES POUR DES COMPOSITIONS PHARMACEUTIQUES
German Title of Invention:
MAKROPHAGENAKTIVIERUNGSFAKTOR FÜR PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
SPC Number:

Dates

Filing date:
05/04/2012
Grant date:
07/06/2017
EP Publication Date:
12/02/2014
PCT Publication Date:
11/10/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/06/2017
EP B1 Publication Date:
07/06/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/04/2018
Expiration date:
05/04/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
07/06/2017
 
 

Name:
Efranat Ltd.
Address:
7 Openhiemer Street, 76701 Rehovot, Israel (IL)

Inventor

Name:
YAMAMOTO, Nobuto
Address:
United States (US)

Priority

Priority Number:
201161472642 P
Priority Date:
07/04/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/14; A61P 31/18; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
201723
Publication date:
07/06/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/08/2018 Outgoing Correspondence 1